Kanada - Kiingereza - Health Canada

dr reddy's laboratories ltd - sodium nitroprusside - solution - 25mg - sodium nitroprusside 25mg - direct vasodilators

Nyuzilandi - Kiingereza - Medsafe (Medicines Safety Authority)

medsurge pharma limited - sodium nitroprusside dihydrate 25 mg/ml - concentrate for injection - 50 mg/2ml - active: sodium nitroprusside dihydrate 25 mg/ml excipient: water for injection - indicated for: - immediate reduction of blood pressure in patients with hypertensive crises. concomitant oral antihypertensive medication should be started while the hypertensive emergency is being brought under control with sodium nitroprusside. - producing controlled hypotension during anaesthesia in order to reduce bleeding in surgical procedures where surgeon and anaesthetist deem it appropriate. - short term therapy of cardiac failure, to enhance cardiac output and lower myocardial oxygen requirements. patients should be commenced on oral therapy as soon as possible.

Ayalandi - Kiingereza - HPRA (Health Products Regulatory Authority)

hospira uk ltd - nitroprusside sodium - pdr for soln for infusion - 50 milligram

Malta - Kiingereza - Medicines Authority

cherubino limited delf building, sliema road, gzira, gzr 1637, malta - sodium nitroprusside - powder for solution for injection - sodium nitroprusside 50 mg - antihypertensives

Armenia - Kiingereza - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

sopharma jsc - nitroprusside (nitroprusside sodium) - powder and solvent for solution for infusion - 30mg

Australia - Kiingereza - Department of Health (Therapeutic Goods Administration)

hospira pty limited - sodium nitroprusside -

Australia - Kiingereza - Department of Health (Therapeutic Goods Administration)

hospira australia pty ltd - sodium nitroprusside -

Ayalandi - Kiingereza - HPRA (Health Products Regulatory Authority)

hospira uk ltd - nitroprusside sodium - pdr for soln for infusion - 50 milligram

Israeli - Kiingereza - Ministry of Health

a.l. medi-market ltd. - nitroprusside sodium anhydrous - powder for solution for infusion - nitroprusside sodium anhydrous 52.75 mg - nitroprusside - nipruss is indicated in:• hypertensive crisis• controlled intraoperative hypotension nipruss is not suitable for permanent therapy.

Nyuzilandi - Kiingereza - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - sodium nitroprusside dihydrate 50mg;   - powder for injection - 50 mg - active: sodium nitroprusside dihydrate 50mg